Eliasson Henrik, Olcén Per, Sjöstedt Anders, Jurstrand Margareta, Bäck Erik, Andersson Sören
Department of Infectious Diseases, Orebro University Hospital, Orebro, Sweden.
Clin Vaccine Immunol. 2008 Aug;15(8):1238-43. doi: 10.1128/CVI.00434-07. Epub 2008 Jun 18.
We have developed and evaluated a novel and simplified whole-blood lymphocyte stimulation assay that focuses on the measurement of gamma interferon after 24 h of stimulation with whole-cell tularemia antigen and a tularemia enzyme-linked immunosorbent assay (ELISA) based on highly purified lipopolysaccharide antigen. Comparison of the kinetics of the two assays and those of the traditional tube agglutination test shows that the cellular immune response can be detected earlier by the lymphocyte stimulation assay. This test already shows a high proportion of positive results during the first week after the onset of the disease, may be applicable in everyday laboratory practice, and has the potential of changing routine diagnostics for tularemia. The new ELISA has a high sensitivity and becomes positive to a high degree during the second week of disease.
我们研发并评估了一种新型的简化全血淋巴细胞刺激试验,该试验着重于用全细胞土拉菌抗原刺激24小时后γ干扰素的测量,以及一种基于高纯度脂多糖抗原的土拉菌酶联免疫吸附测定(ELISA)。对这两种检测方法以及传统试管凝集试验的动力学比较表明,淋巴细胞刺激试验能够更早地检测到细胞免疫反应。该检测在疾病发作后的第一周内就已显示出高比例的阳性结果,可能适用于日常实验室实践,并且有改变土拉菌常规诊断方法的潜力。新型ELISA具有高灵敏度,在疾病的第二周时高度呈阳性。